The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
Pancreatic ductal adenocarcinoma is a highly malignant tumor with poor prognosis, and the biomarkers for the early diagnosis, targeting therapy, and prognosis are still not clinically available. This study investigated the expression of forkhead box P1 and forkhead box O3a proteins in human pancreat...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-04-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317699129 |
id |
doaj-663b1e11dad240c6829c449086e1102c |
---|---|
record_format |
Article |
spelling |
doaj-663b1e11dad240c6829c449086e1102c2021-05-03T00:43:32ZengIOS PressTumor Biology1423-03802017-04-013910.1177/1010428317699129The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomasXin Luo0Zhulin Yang1Xiao Liu2Ziru Liu3Xiongying Miao4Daiqiang Li5Qiong Zou6Yuan Yuan7Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, P.R. ChinaPancreatic ductal adenocarcinoma is a highly malignant tumor with poor prognosis, and the biomarkers for the early diagnosis, targeting therapy, and prognosis are still not clinically available. This study investigated the expression of forkhead box P1 and forkhead box O3a proteins in human pancreatic ductal adenocarcinoma tumor tissues and pancreatic tissues with and without benign lesions using immunohistochemical staining. Results showed that the positive rates of forkhead box P1 and forkhead box O3a protein expression were significantly lower in pancreatic ductal adenocarcinoma tumors compared to peritumoral tissues, benign pancreatic tissues, and normal pancreatic tissues (p < 0.01). Pancreatic tissues with negative forkhead box P1 and forkhead box O3a protein expression exhibited dysplasia or intraepithelial neoplasia. The positive rates of forkhead box P1 and forkhead box O3a expression were significantly lower in cases with tumor mass >5 cm, lymph node metastasis, invasion to surrounding tissues and organs, and tumor–node–metastasis III + IV stage disease compared to cases with tumor mass ⩽5 cm (p < 0.05), no lymph node metastasis (p < 0.001 and p = 0.001, respectively), no invasion (p = 0.003 and p = 0.004, respectively), and tumor–node–metastasis I or II stage disease (p < 0.05). Kaplan–Meier survival analysis showed that pancreatic ductal adenocarcinoma patients with negative forkhead box P1 and forkhead box O3a expression survived significantly shorter than patients with positive forkhead box P1 and forkhead box O3a expression (p = 0.000). Cox multivariate analysis revealed that negative forkhead box P1 and forkhead box O3a expression was an independent poor prognosis factor in pancreatic ductal adenocarcinoma patients. The area under the curve of a receiver operating characteristic curve was 0.642 for forkhead box P1 (95% confidence interval: 0.553–0.730) and 0.655 for forkhead box O3a (95% confidence interval: 0.6568–0.742). Loss of forkhead box P1 and forkhead box O3a protein expression is associated with carcinogenesis, progression, and poor prognosis in patients with pancreatic ductal adenocarcinomas.https://doi.org/10.1177/1010428317699129 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xin Luo Zhulin Yang Xiao Liu Ziru Liu Xiongying Miao Daiqiang Li Qiong Zou Yuan Yuan |
spellingShingle |
Xin Luo Zhulin Yang Xiao Liu Ziru Liu Xiongying Miao Daiqiang Li Qiong Zou Yuan Yuan The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas Tumor Biology |
author_facet |
Xin Luo Zhulin Yang Xiao Liu Ziru Liu Xiongying Miao Daiqiang Li Qiong Zou Yuan Yuan |
author_sort |
Xin Luo |
title |
The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas |
title_short |
The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas |
title_full |
The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas |
title_fullStr |
The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas |
title_full_unstemmed |
The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas |
title_sort |
clinicopathological significance of forkhead box p1 and forkhead box o3a in pancreatic ductal adenocarcinomas |
publisher |
IOS Press |
series |
Tumor Biology |
issn |
1423-0380 |
publishDate |
2017-04-01 |
description |
Pancreatic ductal adenocarcinoma is a highly malignant tumor with poor prognosis, and the biomarkers for the early diagnosis, targeting therapy, and prognosis are still not clinically available. This study investigated the expression of forkhead box P1 and forkhead box O3a proteins in human pancreatic ductal adenocarcinoma tumor tissues and pancreatic tissues with and without benign lesions using immunohistochemical staining. Results showed that the positive rates of forkhead box P1 and forkhead box O3a protein expression were significantly lower in pancreatic ductal adenocarcinoma tumors compared to peritumoral tissues, benign pancreatic tissues, and normal pancreatic tissues (p < 0.01). Pancreatic tissues with negative forkhead box P1 and forkhead box O3a protein expression exhibited dysplasia or intraepithelial neoplasia. The positive rates of forkhead box P1 and forkhead box O3a expression were significantly lower in cases with tumor mass >5 cm, lymph node metastasis, invasion to surrounding tissues and organs, and tumor–node–metastasis III + IV stage disease compared to cases with tumor mass ⩽5 cm (p < 0.05), no lymph node metastasis (p < 0.001 and p = 0.001, respectively), no invasion (p = 0.003 and p = 0.004, respectively), and tumor–node–metastasis I or II stage disease (p < 0.05). Kaplan–Meier survival analysis showed that pancreatic ductal adenocarcinoma patients with negative forkhead box P1 and forkhead box O3a expression survived significantly shorter than patients with positive forkhead box P1 and forkhead box O3a expression (p = 0.000). Cox multivariate analysis revealed that negative forkhead box P1 and forkhead box O3a expression was an independent poor prognosis factor in pancreatic ductal adenocarcinoma patients. The area under the curve of a receiver operating characteristic curve was 0.642 for forkhead box P1 (95% confidence interval: 0.553–0.730) and 0.655 for forkhead box O3a (95% confidence interval: 0.6568–0.742). Loss of forkhead box P1 and forkhead box O3a protein expression is associated with carcinogenesis, progression, and poor prognosis in patients with pancreatic ductal adenocarcinomas. |
url |
https://doi.org/10.1177/1010428317699129 |
work_keys_str_mv |
AT xinluo theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT zhulinyang theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT xiaoliu theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT ziruliu theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT xiongyingmiao theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT daiqiangli theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT qiongzou theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT yuanyuan theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT xinluo clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT zhulinyang clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT xiaoliu clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT ziruliu clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT xiongyingmiao clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT daiqiangli clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT qiongzou clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas AT yuanyuan clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas |
_version_ |
1721486263490445312 |